Phase 1, phase 2, and phase 3 studies

Category: Clinical trials · Editorial Review: Updated 20 October 2026 · 3 minute read

Early studies ask early questions

Phase 1 studies commonly focus on safety, tolerability, and dose-related questions. They may be small and may not be designed to establish effectiveness. Participants can receive an intervention whose best dose and risks are still being investigated. A favorable early report should therefore be read as preliminary evidence rather than a definitive treatment recommendation.

Later studies build the evidence

Phase 2 studies usually explore activity or effectiveness while continuing to assess safety. Phase 3 studies often compare an intervention with an appropriate alternative in a larger population. Designs vary, and some programs combine phases. The label alone is not enough: read the study’s objective, participant criteria, comparator, endpoints, and planned follow-up.

Completion is not success

A completed study may find no benefit, identify safety problems, or produce results that remain uncertain. Likewise, being in a late phase does not guarantee approval or availability. Ask for the results rather than only the phase label. If a clinic advertises a phase 3 product, confirm whether that description applies to the exact product and condition being offered.

Your role as a participant

Research aims to generate reliable knowledge, and an individual participant may or may not benefit. Ask which procedures are research-related, how assignment works, and what follow-up is required. Understanding the study phase helps you frame expectations and discuss participation with a specialist who knows your condition and current treatment options.

Continue exploring

• Randomization and comparison groups
• Clinical trial registration is not treatment approval
• Inclusion and exclusion criteria in cell therapy trials
• Prepare your consultation checklist

Sources & further reading

• National Cancer Institute — How Clinical Trials Work
• ISSCR — Guide to Stem Cell Treatments

Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.